Mölnlycke and AROA partner to expand access to Endoform in the US
Mölnlycke Health Care has entered an exclusive agreement with AROATM to co-promote EndoformTM in the United States in post-acute settings, effective 16 October 2026.
Endoform™ is AROA Biosurgery's regenerative wound care product, used to support healing in chronic and complex wounds. The arrangement combines Endoform, which incorporates AROA’s proprietary AROA ECM™ technology, with Mölnlycke’s established market leading position and commercial reach. It is intended to expand access to Endoform in the US post-acute setting.
The partnership marks an important milestone for Mölnlycke’s post-acute care business in the US, strengthening its advanced wound care offering and supporting its ambition to make effective solutions available to more healthcare professionals and patients.
Brian Ward, AROA Founder and CEO, said “We welcome the opportunity to partner with Mölnlycke, a well-established advanced wound care business known for excellence. Mölnlycke’s deep expertise in wound care and broad commercial footprint provide a strong platform to bring Endoform to more clinicians and patients.”
Craig Kennedy, Mölnlycke VP Americas, commented “Improving wound care requires strong partnerships and continued innovation. Our collaboration with AROA reflects a shared commitment to advancing clinical practice, supporting healthcare professionals, and improving patient outcomes. By adding Endoform to our advanced wound dressing portfolio, we’re expanding the solutions available to clinicians and addressing the diverse needs of the patients they serve.”
AROA will retain ownership of Endoform and AROA ECM and will continue to manufacture, distribute and supply Endoform.
*AROA ECM is a naturally derived extracellular matrix (ECM) technology that supports the body's healing processes by providing the structure and biological signals needed for new tissue growth and repair.
Latest news
-
Mölnlycke launches MyFit™ by Biogel® to bring more inclusive sizing to surgical gloves
Atlanta, Georgia. 13 October 2026. No two pairs of hands are the same, yet surgical glove sizing has changed little over time. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, is launching MyFit™ by Biogel®, a more inclusive range of surgical glove fit options designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
-
Mölnlycke launches Biogel® Radiation Protection® gloves to tackle low adoption of hand protection in radiation-guided surgical procedures
Clinicians’ hands can receive up to 1,000 times more radiation than other parts of the body during image-guided procedures1; yet, radiation-attenuating gloves are used in only 10% of applicable cases2, putting healthcare professionals at risk of the damaging effects of radiation.
-
Mölnlycke to separate its surgical solutions business into a standalone company
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.
-
Mölnlycke Recognized with Cardinal Health 2026 Rising Star Award
Mölnlycke Health Care has been honored with the Cardinal Health 2026 Rising Star Award, recognizing outstanding performance as a new member of the Cardinal Health Performance Plus Program.The award was presented during Cardinal Health's National Sales Meeting, held the week of August 9th, and reflects the strength of the partnership between the two organizations across Advanced Wound Care, Patient Positioning, and Antiseptics.
-
Changes to Mölnlycke Health Care Board of Directors
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
-
Mölnlycke Health Care accelerates U.S. growth journey with three wound care product launches
Peachtree Corners, GA. July 7, 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, has launched three product innovations in the U.S. since the start of 2026. Designed to expand access to advanced wound care solutions and strengthen the company’s U.S. presence, the portfolio expansion also supports long-term value creation across key market segments.
-
Mölnlycke Health Care announces Andreas Johansson as Interim Chief Financial Officer
Gothenburg, Sweden. Wednesday 15 April 2026. Mölnlycke Health Care announces today the appointment of Andreas Johansson as Interim Chief Financial Officer (CFO), with immediate effect.
-
Filippa Stenberg joins Mölnlycke Board of Directors
-
Mölnlycke advocates a holistic approach to healthcare sustainability
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.